Key facts
- Spine Chronicle Japan’s last known valuation is $2.6M (Dec 2020).
- It has raised $2.8M; the latest was Later Stage VC ($870K) in Jan 2025.
- Notable investors include Intellectual Property Acceleration Program for Startups, QR Investment, Beyond Japan, Diamond Medino Capital, INDEE Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Spine Chronicle Japan
- ·The full record, as it builds
Funding rounds
No funding rounds for Spine Chronicle Japan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spine Chronicle Japan
Manufacturer of medical equipment intended to tackle problems in current surgical practice. The company develops a prototype treatment device and services to cure spinal surgery, osteoporotic vertebral fractures, and lumbar spinal canal stenosis diseases, enabling patients to receive better treatment.
- Sector
- Healthcare
- HQ
- Kanazawa, Japan
- Founded
- 2020
- Website
- s-chronicle.co.jp/
- Ownership
- Privately Held (backing)
Spine Chronicle Japan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spine Chronicle Japan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spine Chronicle Japan in its N-PORT filings yet. We sweep new filings monthly.